These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 570784)

  • 1. [Treatment of hyperprolactinemic conditions with bromoergocryptine].
    Sas M; Godó G; Morvay J
    Zentralbl Gynakol; 1978; 100(22):1501-7. PubMed ID: 570784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2alpha-bromoergocryptine in the management of the amenorrhea-galactorrhea syndrome. Clinical and endocrinological evaluation of response to treatment.
    Barreca P; Giannola C; Palisi F
    Acta Eur Fertil; 1978 Mar; 9(1):21-9. PubMed ID: 567920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bromocriptine treatment of amenorrhea with hyperprolactinemia and galactorrhea].
    Hiroi M; Kawakoshi S; Kaneko N
    Horumon To Rinsho; 1983 Jan; 31(1):95-9. PubMed ID: 6682727
    [No Abstract]   [Full Text] [Related]  

  • 4. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
    Abraham G
    Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of the long-term use of parlodel in different forms of lactorrhea].
    Mel'nichenko GA; Pishulin AA; Gitel' EG; Nazarenko VA
    Sov Med; 1984; (1):59-64. PubMed ID: 6701657
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of bromocriptine on patients with hyperprolactinemia and amenorrhea.
    Meduri M; Deodato M; Bramanti P; Volpe A; Grasso A; Di Perri R
    Acta Neurol (Napoli); 1980 Feb; 2(1):15-22. PubMed ID: 7190350
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment with 2-brom-alfa ergocriptine in the syndrome amenorrhea-galactorrhea.
    Sirbu P; Cioltei A; Simionescu L; Dumbravescu A; Sedan E; Titiriga L; Mîtulescu V
    Acta Eur Fertil; 1979 Dec; 10(4):177. PubMed ID: 552769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine. Clinical experience in the induction of pregnancy in amenorrhea-galactorrhea syndrome.
    Zárate A; Canales ES; Forsbach G; Fernández-Lazala R
    Obstet Gynecol; 1978 Oct; 52(4):442-4. PubMed ID: 714326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma.
    Jewelewicz R
    Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of bromo-ergocryptine on serum hPRL, hLH, hFSH, and estradiol 17-beta in women with galactorrhea-amenorrhea.
    Dickey RP; Stone SC
    Obstet Gynecol; 1976 Jul; 48(1):84-9. PubMed ID: 934580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian refractoriness to gonadotropins in cases of inappropriate lactation: restoration of ovarian function with bromocryptine.
    Mroueh AM; Siler-Khodr TM
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1398-401. PubMed ID: 1036743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Longtime study on bromoergocryptine therapy and pyridoxine therapy of amenorrhea-galactorrhea].
    Schindler AE; Plieninger M; Zubke W; Göser R; Keller E
    Arch Gynecol; 1979 Jul; 228(1-4):596. PubMed ID: 573598
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine-induced pregnancies in the amenorrhoea-galactorrhoea syndrome.
    Mustaffa BE; Khalid BA; Satgunasingam N; Adeeb N; Tan PL; Chandran S
    Med J Malaysia; 1983 Sep; 38(3):237-43. PubMed ID: 6672568
    [No Abstract]   [Full Text] [Related]  

  • 15. [2-bromo-alpha-ergocryptine in the treatment of luteal insufficiency].
    Nappi C; Votino F; Mattera P; Montemagno U
    Minerva Ginecol; 1979 Apr; 31(4):273-80. PubMed ID: 572516
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of the amenorrhea-galatorrhea-anovulation syndrome with bromocryptin and the results].
    Markovski N; Ivanov S
    Akush Ginekol (Sofiia); 1980; 19(1):46-52. PubMed ID: 7377513
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remote results of treatment of galactorrhea-amenorrhea syndromes and functional sterility with increased prolactin concentration by means of bromocriptine (Parlodel-Sandoz)].
    Tomala J; Dudkiewicz J; Blecharz AJ
    Ginekol Pol; 1980 Mar; 51(3):255-8. PubMed ID: 6771191
    [No Abstract]   [Full Text] [Related]  

  • 18. Variation of serum prolactin-releasing activity in women with the galactorrhea-amenorrhea syndrome after bromocriptine treatment.
    Takahashi K; Minato K; Ikeno N; Watanabe M; Endo H; Yamamoto H
    Am J Obstet Gynecol; 1983 May; 146(1):74-9. PubMed ID: 6405619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bromoergocryptine (CB 154) and pregnancy. Notes on 2 cases].
    Pagliani A; Modena G
    Minerva Ginecol; 1979 Jun; 31(6):461-5. PubMed ID: 492588
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine.
    Lamberts SW; Seldenrath HJ; Kwa HG; Birkenhäger JC
    J Clin Endocrinol Metab; 1977 Jan; 44(1):180-4. PubMed ID: 576229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.